Literature DB >> 35403149

A Large Thymoma Resected via Left Antero-lateral Thoracotomy.

Cornel Savu1,2, Alexandru Melinte1, Alexandru Gibu1, Ionut Hallabrin1, Alexandru Zafiu1, Vasilica-Adrian Tudor1, Camelia Diaconu3,4, Florentina Gherghiceanu5, Florentina Furtunescu6, Daniel Radavoi7,8, Irina Balescu9, Nicolae Bacalbasa10,11.   

Abstract

Background/Aim: Thymomas are a rare type of mediastinal tumors with a slow growth rate. Because of this, they are well tolerated and patients usually present with large masses, which can extend in either of the thoracic cavities. The surgical approach for such tumors is dictated by the size and localization of the mass. Case Report: We present the case of a patient with a large thymoma, resected through surgery performed by left antero-lateral thoracotomy. The patient presented in our clinic with a persistent cough, dyspnea, chest pain and tightness. Standard thoracic X-ray revealed a bilateral increase in size of the mediastinal shadow, mainly on the left side, with well-defined margins and subcostal intensity. A thoracic computed tomography (CT) scan discovered a tumoral mass within the antero-superior mediastinum, with compression of the mediastinal organs; presentation being suggestive for a thymoma. Surgery was performed, removing a 15/13/10 cm thymoma with a weight of 1126 g. Pathological examination as well as immunohistochemistry confirmed our diagnosis of type AB thymoma, stage I Masaoka-Koga.
Conclusion: In conclusion, surgical treatment remains the main therapeutic option in thymomas, but it is often difficult to perform due to tumor size and local invasion. However, even in large thymomas of stages I and II, surgery can be performed using an antero-lateral thoracotomy. Copyright 2021, International Institute of Anticancer Research.

Entities:  

Keywords:  WHO prognosis; antero-lateral thoracotomy; staging; thymoma; thymoma type

Year:  2021        PMID: 35403149      PMCID: PMC8988950          DOI: 10.21873/cdp.10048

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  43 in total

1.  Azygos Vein Aneurysm Mimicking a Mediastinal Mass.

Authors:  Cornel Savu; Alexandru Melinte; Irina Balescu; Nicolae Bacalbasa
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Unique case of atypical type A thymoma with vertebral metastasis and high 18-fluorodeoxyglucose avidity.

Authors:  Marco Chiappetta; Mirella Marino; Francesco Facciolo
Journal:  ANZ J Surg       Date:  2018-08-17       Impact factor: 1.872

3.  Surgical treatment of single and multiple thymoma recurrences.

Authors:  Angelo Carretta; Paola Ciriaco; Piergiorgio Muriana; Alessandro Bandiera; Giampiero Negri
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-10-22

4.  Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma.

Authors:  Najib Safieddine; Geoffrey Liu; Kris Cuningham; Tsao Ming; David Hwang; Anthony Brade; Andrea Bezjak; Stefan Fischer; Wei Xu; Sassan Azad; Marcelo Cypel; Gail Darling; Kazu Yasufuku; Andrew Pierre; Marc de Perrot; Tom Waddell; Shaf Keshavjee
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

5.  Prognostic impact of tumour size in completely resected thymic epithelial tumours.

Authors:  Takayuki Fukui; Koichi Fukumoto; Toshiki Okasaka; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Akihiro Hirakawa; Hisashi Tateyama; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2016-12       Impact factor: 4.191

6.  Tobacco smoking and alcohol consumption as risk factors for thymoma - A European case-control study.

Authors:  Mikael Eriksson; Linda Kaerlev; Preben Johansen; Noemia Afonso; Wolfgang Ahrens; Altamiro Costa-Pereira; Pascal Guénel; Karl-Heinz Jöckel; Agustin Llopis Gonzalez; Franco Merletti; Maria Morales Suárez-Varela; Brigitte Trétarre; Gun Wingren; Lorenzo Richiardi; Svend Sabroe
Journal:  Cancer Epidemiol       Date:  2019-06-26       Impact factor: 2.984

7.  Gianturco Z-Stent Fixation of a Modified Iliac Limb Stent-Graft Endoprosthesis for the Treatment of Malignant Superior Vena Cava Syndrome.

Authors:  Jeffrey Forris Beecham Chick; Matthew L Osher; Kyle J Cooper; Wael E Saad; David M Williams; Minhaj S Khaja
Journal:  Ann Vasc Surg       Date:  2017-06-23       Impact factor: 1.466

8.  Relationship Between Computed Tomography Imaging Features and Clinical Characteristics, Masaoka-Koga Stages, and World Health Organization Histological Classifications of Thymoma.

Authors:  Xiaowei Han; Wenwen Gao; Yue Chen; Lei Du; Jianghui Duan; Hongwei Yu; Runcai Guo; Lu Zhang; Guolin Ma
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244

9.  Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.

Authors:  Arun Rajan; Christopher R Heery; Anish Thomas; Andrew L Mammen; Susan Perry; Geraldine O'Sullivan Coyne; Udayan Guha; Arlene Berman; Eva Szabo; Ravi A Madan; Leomar Y Ballester; Stefania Pittaluga; Renee N Donahue; Yo-Ting Tsai; Lauren M Lepone; Kevin Chin; Fiona Ginty; Anup Sood; Stephen M Hewitt; Jeffrey Schlom; Raffit Hassan; James L Gulley
Journal:  J Immunother Cancer       Date:  2019-10-21       Impact factor: 13.751

10.  An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymoma.

Authors:  Jun Dong; Shaofei Yuan; Boyang Chang; Jinsheng Huang; Xiaojing Geng; Xiuyu Cai; Pili Hu; Bei Zhang; Liangping Xia; Peihong Wu
Journal:  Cancer Imaging       Date:  2019-12-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.